(Q38115716)

29 August 2017

title

Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling? (English)

1 reference

29 August 2017

Marine Baptissart

1

1 reference

29 August 2017

Aurelie Vega

2

1 reference

29 August 2017

Emmanuelle Martinot

3

1 reference

29 August 2017

Silvère Baron

4

1 reference

29 August 2017

Jean-Marc A Lobaccaro

5

1 reference

29 August 2017

David H Volle

6

1 reference

29 August 2017

publication date

20 June 2013

1 reference

Cellular and Molecular Life Sciences

29 August 2017

published in

1 reference

29 August 2017

volume

70

1 reference

29 August 2017

issue

23

1 reference

29 August 2017

page(s)

4511-4526

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-013-1387-0

29 August 2017

exact match

0 references

cites work

Biliary function and its regulation

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

The enzymes, regulation, and genetics of bile acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile salt biotransformations by human intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

The RXR heterodimers and orphan receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Targeting farnesoid X receptor for liver and metabolic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Identification of a nuclear receptor for bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile acids: natural ligands for an orphan nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Endogenous bile acids are ligands for the nuclear receptor FXR/BAR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

FXR, a multipurpose nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Role of bile acids and bile acid receptors in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

The small heterodimer partner is a gonadal gatekeeper of sexual maturation in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Expression and activation of the farnesoid X receptor in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Nuclear receptors in human immune cells: expression and correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Effects of FXR in foam-cell formation and atherosclerosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile acids: from digestion to cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile salt transporters: molecular characterization, function, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Regulation of carbohydrate metabolism by the farnesoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Immunolocalization of farnesoid X receptor (FXR) in mouse tissues using tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Upregulation of scavenger receptor class B type I expression by activation of FXR in hepatocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

FXR agonist GW4064 increases plasma glucocorticoid levels in C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

The farnesoid X receptor regulates transcription of 3beta-hydroxysteroid dehydrogenase type 2 in human adrenal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Effect of chenodeoxycholic acid on 11beta-hydroxysteroid dehydrogenase in various target tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

New insights regarding glucocorticoids, stress and gonadotropin suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

UDP-Glucuronosyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Human Uridine Diphosphate-Glucuronosyltransferase UGT2B7 Conjugates Mineralocorticoid and Glucocorticoid Metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile acid-activated receptors in the treatment of dyslipidemia and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Farnesoid X receptor is essential for normal glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Transient impairment of the adaptive response to fasting in FXR-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Cholesterol and male fertility: what about orphans and adopted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Cell biology of Leydig cells in the testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

The potential roles of estrogens in regulating Leydig cell development and function: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Novel pathways of bile acid metabolism involving CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Vitamin D receptor as an intestinal bile acid sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Interactions of hepatic cytochromes P-450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Cytochrome P450 3A gene variation, steroid hormone serum levels and prostate cancer--The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Expression of cytochrome P450 3A4 and its clinical significance in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Sulfonation and molecular action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile acid profiles in urine of patients with liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Urinary bile acids in late pregnancy and in recurrent cholestasis of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Human constitutive androstane receptor mediated methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Androgen and estrogen sulfotransferases of the rat liver: physiological function, molecular cloning, and in vitro expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Human sulfotransferase SULT2A1 pharmacogenetics: genotype-to-phenotype studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Targeted overexpression of androgen receptor with a liver-specific promoter in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Metabolism of 26,26,26,27,27,27-F6-1 alpha,23S,25-trihydroxyvitamin D3 by human UDP-glucuronosyltransferase 1A3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Cellular localization of uridine diphosphoglucuronosyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

The cynomolgus monkey (Macaca fascicularis) is the best animal model for the study of steroid glucuronidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Prostate cancer and polymorphism D85Y in gene for dihydrotestosterone degrading enzyme UGT2B15: Frequency of DD homozygotes increases with Gleason Score

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Development of FXR, PXR and CAR agonists and antagonists for treatment of liver disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Selective estrogen receptor modulation: concept and consequences in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Aromatase inhibitors as adjuvant treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Faecal bile acids and clostridia in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Steroids and cancer: faecal bile acid screening for early detection of cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Plasma deoxycholic acid concentration is elevated in postmenopausal women with newly diagnosed breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile acids influence the growth, oestrogen receptor and oestrogen-regulated proteins of MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Alteration in male reproductive system in experimental cholestasis: roles for opioids and nitric oxide overproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Male hypogonadism in cirrhosis and after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile acid metabolism and the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Bile acid signaling in fetal tissues: implications for intrahepatic cholestasis of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1387-0

Plasma bile acids and risk of breast cancer

21 January 2018

1 reference

12 December 2020

Effects of glucocorticoids on carbohydrate metabolism

1 reference

12 December 2020

Molecular interaction between the glucocorticoid receptor and MAPK signaling pathway: a novel link in modulating the anti-inflammatory role of glucocorticoids.

1 reference

12 December 2020

Inhibition of androgen action by dehydroepiandrosterone sulfotransferase transfected in PC-3 prostate cancer cells

1 reference

12 December 2020

In VivoImaging of Farnesoid X Receptor Activity Reveals the Ileum as the Primary Bile Acid Signaling Tissue

1 reference

12 December 2020

Fecal steroid metabolites and breast cancer risk

1 reference

12 December 2020

Cancer incidence after cholecystectomy--a cohort study with 30 years follow-up

1 reference

12 December 2020

Cortisol metabolism in vitro--III. Inhibition of microsomal 6 beta-hydroxylase and cytosolic 4-ene-reductase

1 reference

12 December 2020

An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer

1 reference

12 December 2020

Breast-gut connection: origin of chenodeoxycholic acid in breast cyst fluid

1 reference

12 December 2020

Etiology of hormone receptor-defined breast cancer: a systematic review of the literature

1 reference

12 December 2020

Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid

1 reference

12 December 2020

Enzymology of human cytosolic sulfotransferases

1 reference

12 December 2020

Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors

1 reference

12 December 2020

Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes

1 reference

12 December 2020

Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue

1 reference

12 December 2020

The estrogen receptor: a model for molecular medicine.

1 reference

12 December 2020

Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.

1 reference

12 December 2020

Paraneoplastic cholestasis associated with prostate carcinoma

1 reference

12 December 2020

Bile acids in human breast cyst fluid: the identification of lithocholic acid

1 reference

12 December 2020

production rates of testosterone in patients with Cushing's syndrome

1 reference

12 December 2020

Consequences of complete bile-duct ligation on the pubertal process in the male rat.

1 reference

12 December 2020

The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians

1 reference

12 December 2020

Obstructive jaundice associated with carcinoma of the prostate

1 reference

12 December 2020

Hypophyseal-gonadal dysfunction in men with non-alcoholic liver cirrhosis.

1 reference

12 December 2020

Glucocorticoids promote hepatic cholestasis in mice by inhibiting the transcriptional activity of the farnesoid X receptor

1 reference

12 December 2020

Effects of nuclear receptor transactivation on steroid hormone synthesis and gene expression in porcine Leydig cells

1 reference

12 December 2020

Consumer-directed models of personal care: lessons from Medicaid

1 reference

12 December 2020

Deciphering the nuclear bile acid receptor FXR paradigm

1 reference

12 December 2020

Levels of plasma C19 steroids and 5 alpha-reduced C19 steroid glucuronides in primates, rodents, and domestic animals

1 reference

12 December 2020

Corticosterone impairs the mRNA expression and activity of 3beta- and 17beta-hydroxysteroid dehydrogenases in adult rat Leydig cells

1 reference

12 December 2020

A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression

1 reference

12 December 2020

10.1007/S00018-013-1387-0

Identifiers

DOI

1 reference

29 August 2017

1 reference